"Bristol-Myers Squibb and Concerto HealthAI have announced plans to apply artificial intelligence (AI) and real-world data to a diverse range of cancers in a multi-year strategic agreement. The collaboration will cover a diverse range of cancers, integrate multiple data sources, and apply AI and machine learning to accelerate clinical trials, enable robust protocol design and generate insights for precision treatment and improved patient outcomes..." Lire la suite
